Preliminary study of ivermectin residues in bovine livers in the Bogota Savanna by Celis-Giraldo, Carmen Teresa et al.
311 
https://doi.org/10.22319/rmcp.v11i2.4992 
Article 
Preliminary study of ivermectin residues in bovine livers in the Bogota 
Savanna 
 
Carmen Teresa Celis-Giraldo a* 
Diego Ordóñez a 
Leonardo Roa a 
Sergio Andrei Cuervo-Escobar b 
Dajane Garzón-Rodríguez a,  
Milena Alarcón-Caballero a 
Luisa Fernanda Merchán a 
 
a Universidad de Ciencias Aplicadas y Ambientales U.D.C.A. Facultad de Ciencias 
Agropecuarias. Bogotá, Colombia. 
b Universidad de Ciencias Aplicadas y Ambientales U.D.C.A. Facultad de Ciencias. 
Bogotá, Colombia. 
 
*Corresponding author: ccelis@udca.edu.co 
 
Abstract: 
The present study tended to determine the ivermectin residues in cattle livers using the 
competitive ELISA technique and correlate gender and age variables with residual 
presence. Also, it was described the histopathological findings in analyzed samples. A 
total of 90 livers of randomly selected cattle were sampled in a type II slaughterhouse 
located in the Bogota Savanna. The samples were analyzed for ivermectin residues using 
the competitive ELISA technique and a histopathological evaluation was performed using 
the H&E technique. Only the 22 % (20/90) of the analyzed samples presented ivermectin 
residues. Of the positive individuals, the majority came from Cogua 35 % (7/20), 
Zipaquira 30 % (6/20) and Sopo 20 % (4/20). The breeds with residues presence 
corresponded to Half-Blood 35 % (7/20), Zebu 25 % (5/20), Normande 20 % (4/20) and 
Jersey x Holstein 15 % (3/20). Eighty five, 85 % (17/20) of the individuals were older 
than 1.5 yr. In regard to the gender variable, the majority of animals were males 65 % 
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(13/20). Of the evaluated animals 3 % (3/90) exceeded the maximum residue limit (> 100 
ppb). No association was found between the presence of residues and the gender and age 
variables (P>0.05). The majority of histopathological changes were mild or moderate, 
with alterations in architecture and inflammatory changes standing out. It was found 
association between the presence of residue and variables microcirculatory alteration, 
inflammatory alteration and changes similar to the cell death (P<0.05). As a conclusion, 
the competitive ELISA test used in this study served as a screening method for the 
detection ivermectin residues in the analyzed samples.  
Key words: Antiparasitic drugs, Ivermectin, ELISA, Liver, Macrocyclic lactones, 
Bovine. 
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Introduction 
 
 
Parasitic diseases are one of the most important causes of economic losses for the 
livestock industry in tropical and subtropical production systems. These diseases have a 
huge prevalence impact related to epidemiological chain factors such as the presence of 
vectors and environmental changes(1). Ivermectin is a popular macrocyclic lactone since 
its introduction to the market(2,3).  This drug is a mixture of two  homologs in a ratio of 
80 % 22,23-dihydroavermectin B1a (H2B1A) and no more than 20 % of 22,23-
dihydroavermectin B1b (H2B1b)
(4). The maximum residue limits (MRL) in the European 
community have been determined to utilize the B1A portion as a marker(5). The 
outstanding use in veterinary medicine is derived from the spectrum activity for the 
control of nematodes and arthropods, generating a remarked interest for research 
development. Additionally, the macrocyclic lactones group has also been used in 
agriculture  for pest control  and in human medicine  mainly for onchocerciasis 
treatment(6,7). 
 
From a pharmacokinetic point of view, studies have shown that the main organ for 
Ivermectin residues detection is the liver in almost all the evaluated species(8,9,10). 
Therefore, due to the huge usage in the field, consumption of viscera and possible toxicity, 
this organ was chosen as the matrix to carry out this study. For detecting residues, several 
methodologies have been developed, liquid chromatography (HPLC) and mass 
spectrometry are the most recommended due to their high sensitivity and selectivity, 
however, they also present certain disadvantages such as complex extraction process and 
expensive equipment is needed(11). Another semi-quantitative-methodologies such as 
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Competitive ELISA are used as screening method in several matrices. Some advantages 
are related to a low cost, fastness with a relative good sensitivity and specificity in 
comparison to HPLC(4,12). 
 
The purpose of this investigation corresponded to determine the presence of ivermectin 
residues in bovine livers from the Bogota, D.C. savanna using the competitive ELISA 
technique, correlating the presence of residues presence with gender and age variables. 
This study also describes the histopathological changes of the evaluated samples. 
 
 
Material and methods 
 
 
Study location 
 
 
Samples were obtained from Zipaquira´s slaughterhouse, which has an average of 200 
animals slaughtered daily. This slaughterhouse is classified as type II, according to 
INVIMA (Decree 1036 of 1991) and the Ministry of Health and is also certified by ISO 
9001: 2008 and NTCGP1000: 2009 normativity. 
 
 
Sample size 
 
 
Considering an error of 10 % and a confidence level of 99 %, the number of analyzed 
livers corresponded to 89. The animals were chosen randomly in the suspension area and 
subsequently identified. Once they were in the evisceration area, approximately 100 g of 
liver were taken in sterile bags for the ELISA test. Each sample was marked, duly labeled, 
refrigerated, transported and later stored at -20 °C until their analysis. At the same time, 
data corresponding to origin, breed, gender, and age of the evaluated animals were 
obtained. 
 
In the standardization phase the liver of a bovine was included as a negative control. This 
animal certainly did not receive any previous treatment with ivermectin. Prior 
authorization from the Bioethics Committee of the U.D.C.A, an 8-d-old calf was 
euthanized using Euthanex® (60 mg/kg, I.V) and liver samples were taken for analysis. 
The pregnant cow belonged to the university and did not receive antiparasitic treatment 
with macrocyclic lactones during pregnancy. 
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Procedure 
 
 
Competitive ELISA test was used for residue detection and quantification. This test uses 
rabbit polyclonal antibodies against ivermectin and the analysis process for each sample 
was carried out considering the kit provider information(13), briefly the amount of active 
ingredient in the samples was expressed as equivalents of ivermectin (ng/ml). In the case 
of the liver, the values that were obtained from the calibration curve were multiplied by 
a factor of 5 in order to express the concentration in ng/g. The equivalents of ivermectin 
corresponded to the maximum percentage of absorbance of each extract read from the 
calibration curve of the seven standards (Table 1). The determination coefficients 
obtained in each calibration curve were considered to calculate the specific residues 
concentration. 
 
Table 1: Concentration of the ivermectin in the standard solutions 
Standard 0 1 2 3 4 5 6 
ng/ml -- 1.25 2.5 5 10 25 50 
 
Each sample was thawed and homogenized with a food processor. The obtained material 
was subjected to an extraction process and therefore residue quantification based on the 
kit supplier parameters. Samples were considered as residually positives when they 
exceeded the kit’s reported limit of detection (LOD) of 8 ppb. The maximum residue limit 
(MRL) for the liver corresponded to 100 ppb, thus considering the reported values in 
Resolution 1382 of 2013 of the Ministry of Health and Social Protection. The samples 
were analyzed in duplicate at the U.D.C.A microbiology laboratory. 
 
 
Histopathological analysis 
 
 
In addition to the sample taken for ELISA analysis, 5 g of liver were obtained for 
histopathological evaluation, conserving them in 10% formaldehyde. Samples were 
processed by hematoxylin and eosin technique in the U.D.C.A pathology laboratory. 
Three zones of the hepatic lobe were evaluated as follows, zone 1, located at a further 
distance from the centrilobular vein, specifically in the periphery of the lobule. Zone 2 
corresponded to the middle of the periphery and centrilobular vein, and the zone 3, it was 
considered as closest to the centrilobular vein. 
 
In aforementioned areas, the following variables were evaluated:  
Alterations in architecture: vacuolation, lobular inversion, canalicular hyperplasia and 
parenchymal fibrosis. 
Microcirculatory alterations: in this case, centrilobular congestion, generalized 
congestion, focal hemorrhage, and edema were considered. 
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Inflammatory alterations: presence of polymorphonuclear, mononuclear and mixed cells. 
An evaluation of the lobular areas was done either. 
Changes similar to cell death: apoptosis and necrosis were considered. 
 
For each of the variables, the degree of the lesion was classified as follows: (0) apparently 
normal, (1) mild, (2) moderate and (3) severe(14). 
 
 
Statistical analysis 
 
 
This study was observational with simple random sampling. The data was recorded in 
Microsoft Office Excel 2016 spreadsheet and analyzed with STATA MP14 statistical 
package. A descriptive analysis of the origin, breed, gender and age variables was carried 
out. To analyze the effect of gender, age and histopathological variables with ivermectin 
concentration, a Chi2 (P<0.05) association test was performed. 
 
 
Results 
 
The coefficients of determination obtained to calculate residue concentration were 97 % 
on average. Most individuals presented levels lower than 8 ppb (78 %), 19 % between 8 
and 100 ppb and only 3 % presented residues over 100 ppb, exceeding the MRL (Figure 
1). 
 
Figure 1: Distribution of ivermectin residues in the evaluated population 
 
 
The population without residues  (LOD <8 ppb)  was mostly originated from Zipaquira 
44 % (28/70), followed by Cogua 26 % (18/70), and to Sopo and Chiquinquira 
respectively corresponded the remaining 10 % (7/70) of the evaluated animals. For the 
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breed variable, the highest proportion of animals were Normande 34 % (24/70), followed 
by Holstein 28 % (20/70) and Half-Blood 23 % (16/70). In the case of the age variable, 
only 13 % (9/70) were animals under 1.5 yr old and 87 % were older than 1.5 yr old. For 
the gender variable, it was observed that 59 % (41/70) of the sampled animals were 
females and 41 % (21/70) were males. 
 
The individuals with residues prescense were mostly originated from Cogua 35 % (7/20), 
Zipaquira 30 % (6/20), Sopo 20 % (4/20). For La Vega, Bogota and Guasca, only one 
individual was positive respectively. The breeds in which residues were found 
corresponded to Half-Blood 35 % (7/20), Zebu 25 % (5/20), Normande 20 % (4/20) and 
Jersey x Holstein 15 % (3/20); for Holstein there was only one individual. 85 % (17/20) 
of the animals were older than 1.5 yr old and the remaining 15 % (3/20) were less than 
1.5 yr old. In terms of the gender variable,  they were molstly males 65 %  (13/20) and 
35 % (7/20) were females. 
 
Only 3 % (3/90) of samples exceeded the MRL. All of the positive animals were male, 
two samples came from Sopo and one from Cogua and two of them were older than 1.5 
yr old.  These  animals were  Half-Blooded,  Holstein and  Jersey x Holstein  breeds 
(Table 2). When performing the Chi2 association test between variables age (P=0.84), 
gender (P=0.06) and ivermectin concentration, no association was found. 
 
Table 2: Descriptive statistics of the population with residues presence 
Variable 
Samples 
with residue 
\ Total 
population 
% 
Samples 
with 
residues 
Concentration (≥ 8 ppb) 
Samples 
>MRL* 
Range Average SE 
Gender:  
Males 13\42 31 8.40-154.72 58.50 14.71 3 
Females 7\48 15 8.32-26.92 16.30 2.38 0 
Origin:  
Cogua 7\25 28 8.86-154.72 37.86 19.58 1 
Sopo 4\11 36 8.32-140.25 86.05 31.92 2 
Zipaquira 6\34 18 8.40-87.65 32.75 10.50 0 
Age:       
< 1.5 yr old 3\12 25 8.86-154.72 60.98 46.96 1 
≥ 1.5 yr old 17\78 22 8.32-140.25 40.68 10.11 2 
Breed **  
Half-Blood 7\23 30 8.32-136.40 33.74 17.45 1 
Zebu 5\12 42 18.28-87.65 34.67 13.32 0 
Normande 6\28 14 8.40-59.22 31.43 8.87 0 
Jersey x 
Holstein 3\4 75 15.12-140.25 61.53 39.56 1 
*MRL= Maximum Residue Limit. 
**Only one individual of Holstein breed exceeded the MRL with 154.72 ppb. 
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For the histopathological analysis, 86 samples were evaluated, and as it was 
mentioned before, 20 livers presented ivermectin residues and 66 livers where 
considered as negative. According to lesion severity and the different variables 
analyzed, the data was recorded in Table 3. It is worth mentioning that no lobular 
inversion and lesions compatible with necrosis were observed in the analyzed 
samples. The majority of changes observed were mild in both cases. For the samples 
without residues, the main changes observed corresponded to the inflammatory level, 
with a mild presence of monocytes stood out (28/66), moderate (6/66) and severe 
(3/66). Mild changes in vacuolization (41/66), hyperplasia (15/66), moderate 
hyperplasia (22/66), mild fibrosis (27/66) and moderate fibrosis (21/66) were also 
described. We found association between variables microcirculatory alteration, 
inflammatory alteration and similar to the cell death (P<0.05) (Table 3). 
 
 
Table 3: Histopathological findings in the studied population 
 
 
 
Severity 
Degree 
LOD 
< 8ppb 
LOD 
≥ 8ppb 
 
P value 
A
rc
h
it
ec
tu
re
 a
lt
er
at
io
n
 Vacuolization 
Normal 21 10  
0.318 Mild 41 7 
Moderate 4 3 
Hyperplasia 
Normal 29 11  
0.447 Mild 15 8 
Moderate 22 1 
Fibrosis 
Normal 18 6  
0.708 Mild 27 11 
Moderate 21 2 
Severe 0 1 
M
ic
ro
ci
rc
u
la
to
ry
 a
lt
er
at
io
n
 
Lobulillar congestion 
Normal 49 2  
0.000* Mild 17 11 
Moderate 0 7 
Generalized congestion 
Normal 64 7  
 
0.000* 
Mild 1 9 
Moderate 0 4 
Severe 1 0 
Focal hemorrhage 
Normal 66 16  
0.006* Mild 0 1 
Moderate 0 3 
Edema 
Normal 66 15  
0.000* Mild 0 6 
Moderate 0 1 
In
fl
am
m
a
to
ry
 
al
te
ra
ti
o
n
 
Polymorphonuclear 
Normal 66 5  
0.000* Mild 0 13 
Moderate 0 2 
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Monocytes 
Normal 29 3  
0.027* Mild 28 15 
Moderate 6 2 
Severe 3 0 
Mixed 
Normal 66 7  
0.000* Mild 0 12 
Moderate 0 1 
Zone 3 
Normal 33 17 0.003* 
Mild 33 3 
S
im
il
ar
 t
o
 
th
e 
ce
ll
 
d
ea
th
 
Apoptosis 
Normal 66 12  
0.000* 
 
Mild 0 7 
Moderate 0 1 
 
P<0.05. 
 
Animals with residues evidence (20) presented alterations on architectural variables as 
follows: 10 samples had vacuolar changes (7 mild and 3 moderate); 9 had canalicular 
hyperplasia (8 mild, 1 moderate) and 14 had portal fibrosis (11 mild, 2 moderate and 1 
severe) (Figure 2). Eighteen (18) samples that contained ivermectin residues presented 
centrilobular congestion (11 mild, 7 moderate); 13 samples presented generalized 
congestion and sinusoidal dilatation (10 mild, 4 moderate) and 4 hemorrhagic foci (1 
mild, 3 moderate) (Figure 3). 
 
Figure 2: Bovine liver without ivermectin residues 
 
A. Normal architecture in the hepatocytes (400X) and B. the portal area (100X).   Architectural changes 
in the hepatic parenchyma of cattle with residues. C. Vacuolar changes, note the presence of 
intracytoplasmic vacuoles (arrow tip) (400x).  D. Mild fibrosis of the portal area (arrow) (100X). 
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Figure 3: Microcirculatory changes in the hepatic parenchyma of cattle positive for 
ivermectin residues. Mild congestion and sinusoidal dilatation were evident 
 
 
In relation to the inflammatory infiltrate, 13 of the 20 animals presented mixed 
infiltration, predominantly by mononuclear cells (15 mild, 1 moderate) in centrilobular 
distribution. Comparatively, in both groups, a wide range of changes were found 
associated to microcirculatory, architectural, inflammatory and cell death (apoptosis) 
processes (Figure 4). In relation to the last alteration, only eight of the analyzed samples 
showed changes associated with similar to cell death, characterized by a multifocal 
distribution in the positive tissues with ivermectin residues (Table 3). 
 
Figure 4: Changes compatible with apoptosis, bovine liver with ivermectin residues 
obtained from a slaughterhouse. Cells with related changes with cellular death (arrows) 
 
 
 
Discussion 
 
 
Ivermectin is an active compound that has been used for almost 20 yr in numerous 
countries and different animal production systems. As a result of its usage, control testing 
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on food products derived from livestock is carried out in order to harmonize the 
commercialization processes. Several studies have been done reporting different 
methodologies for this purpose, such as the competitive ELISA technique. This method 
was developed before(4), using rabbit produced polyclonal antiserum and the limit of 
detection (LOD) was 1.6 μg/kg and the antibodies presented a cross-reaction with 
doramectin but not with moxidectin. In that study, negative liver (1.6 ng/g), 100 ng/g 
ivermectin fortified liver and 0.5 mg/kg topically treated liver samples from animals 
slaughtered on day 7, 14, 21 and 28 were analyzed. In this case, ivermectin levels on d 7 
post-treatment were 52.7 ng/g decreasing to 4.1 ng/g by d 28. The data was confirmed by 
another complementary technique such as high-performance liquid chromatography 
(HPLC). The range of both tests was 1 to 58 ng/g with a close correlation (r = 0.99). 
 
In a study carried out by other authors(12) where an ELISA was developed for the detection 
of multiple avermectins (abamectin, eprinomectin, and ivermectin) the modified 
avermectin 4C-O-succinoylavermectin was conjugated with bovine albumin and 
ovoalbumin as immunogens for polyclonal antibodies the preparation. The LOD for this 
test corresponded to 1.06 ng/ml for all three avermectins. The percentage of recovery 
ranged from 53.8 % to 80.6 % and it was similar to previous reports using HPLC, 
converting this technique as a rapid method for screening avermectins in bovine liver. In 
the present study the LOD of 8 ppb (reported by the manufacturer), 70 samples were 
under, 17 between 8 and 100 ppb and only 3 exceeded 100 ppb. It is important to bear in 
mind that in this case no additional confirmatory tests were performed, however 
considering the obtained data it would be relevant to expand this kind of approach in other 
production systems with a greater usage of this active compound, situation that has been 
reported in other country areas. 
 
Turning to the MRL, only 3 % of the samples exceeded the maximum value reported by 
Colombian authorities (>100 ppb), this could be considered as a low level. In Colombia, 
a study determining residuality of organophosphorus, carbamates and ivermectin 
insecticides in raw milk from farms in tropical areas. Of 609 samples analyzed, 37.44 % 
contained organophosphate levels exceeding the MRL, with Magdalena Region 
containing almost all the positive samples. Although, 180 milk samples were analyzed 
for ivermectin detection and quantification but any sample exceeded the MRL(15). Data 
obtained in this study were similar to the observed in other countries as Mexico, where 
evaluated the presence of ivermectin residues due to the increased use of this molecule 
on the farms. In this case, 234 liver samples were taken during the course of a month and 
analyzed by HPLC. Only one sample was not within parameters (149 μg/kg), situation 
that was similar to another previously reported by a control scheme for this area(16).  
 
The aforementioned data differ from another reported in Brazil. Due to residuality 
problems during 2010 several detection techniques were developed in muscle matrices, 
allowing the establishment of the MRL and pertinent measures were taken to exercise 
drug control within the production systems(17). Some of the strategies used corresponded 
to education campaigns for producers in order to prevent parasitic disease by management 
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and medication use, considering several factors that can lead to exceed the residues 
maximum permitted levels, such as product formulation, active ingredient 
physicochemical properties, overdose, administration method, product use in non-
recommended species, heterogeneous animal lots, and finally non-compliance with 
withdrawal times(2,11). 
 
In terms of the epidemiological characteristics, no association was observed between 
gender and age variables with the residues presence. Despite that fact, there was a greater 
presence of residues in males than females. Considering this, reported pharmacokinetic 
data show that there are differences related to gender and plasma disposition of the active 
ingredient. These characteristics have been studied in various animal species and 
specifically for cattle, found differences related to gender in terms of plasma 
concentration when they evaluated ivermectin and doramectin, bioavailability was 10% 
higher in heifers than in steers for both molecules(18). This difference was associated with 
the amount of adipose tissue in males and females, considering the characteristics of the 
active ingredient such as the high liposolubility of the endectocide agent that promotes its 
storage in this tissue and favors its persistence(9). 
 
Despite that residues were observed in females, the percentage found was very low (15%), 
possibly the evaluated animals were in nonlactating (dry) period, driving to their discard 
and slaughter, but any case exceeded the limits and most relevant data was found in males. 
Even so, it is important to bear in mind that the only avermectin approved for dairy 
farming is eprinomectin and that other factors, such as hormonal influence can affect drug 
metabolism in terms of its transformation and elimination(15,19). 
 
The histopathological evaluation of this study allowed a wide range of hepatic 
parenchymal alteration findings, even in animals with and without residues. When the 
microcirculatory changes were evaluated, some animals with residues presented a greater 
degree of the congestive changes and hemorrhagic foci severity, suggesting a greater 
susceptibility to develop disorders associated with alterations of the vascular network of 
the liver parenchyma; however, the number of animals that developed these kind of 
disorders does not turn out to be significant. 
 
Numerous chemical substances suffer part of their biotransformation in the hepatic tissue, 
this also means that a major part of these compounds could generate cellular alterations 
of the parenchyma, leading to possible disorders associated to liver function alterations 
such as protein synthesis, carbohydrate transformation and lipid metabolism. Included 
amongst these are pharmaceuticals, bacterial toxins, and toxic plants. In this sense, the 
unique or concomitant effect of this type of compounds on the analyzed samples cannot 
be ruled out. 
 
A study conducted in rats for the evaluation of the effect of massive and long-lasting 
treatments with ivermectin among other molecules against various parasites, showed 
some clinical alterations compatible with hepatotoxicity and anatomopathological 
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changes revealed architecture distortion, hepatocellular necrosis, and Kupffer cell 
hyperplasia(20). In hyperacute cases of intoxication in goats, sudden death is reported 
without systemic pathological alterations(21). In humans, a case report showed the 
hepatotoxic potential of ivermectin after administration in a patient with filarial 
parasitism, finding intralobular inflammatory infiltrate and accumulation of ceroid 
pigment, perivenular necrosis, necrosis and apoptosis(22). According to the international 
guidelines, the acceptable daily intake established for humans is 10 μg/kg (600 
μg/person/d)(5), levels that were not observed in the analyzed samples. It is worth noting 
that comparatively with these reports, the present study also evidenced changes similar to 
apoptosis only in animals with residues presence, however further studies like 
imnunohistochemistry should be conducted in order to clarify the association between 
residues and hepatic lesion development. 
 
The ivermectin poisoning has been associated with overdosing or with the presence of a 
P-glycoprotein mutation that promotes the development of neurological symptoms in 
several animal species. The human intoxication has been associated with mild to moderate 
effects of a Mazzotti reaction and encephalopathy linked to microfilaricidal therapy or 
macrocyclic lactones exposure(23). 
 
 
Conclusions and implications 
 
 
In conclusion, the competitive ELISA test used in this study served as a screening method 
to analyze ivermectin residues in bovine livers. Only 3 % of the samples exceeded the 
MRL and no correlation was found between the presence of residues with gender and age 
variables (P>0.05). The majority of the histopathological changes were mild or moderate, 
with alterations in architecture and inflammatory changes standing out. Exist statistical 
association between the presence of residue of ivermectin and variables microcirculatory 
alteration, inflammatory alteration and changes similar to the cell death (P<0.05).  
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